Pulmonary strongyloidiasis in a patient receiving prednisolone therapy

Internal Medicine

Volumn 43, Issue 8, 2004, Pages 731-736

  Namisato, Shun ^a,b   Motomura, Kazuhisa ^b   Haranaga, Shusaku ^a   Hirata, Tetsuo ^a   Toyama, Masato ^a   Shinzato, Takashi ^a   Higa, Futoshi ^a   Saito, Atsushi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Department of Neurosurgery   (Japan)

Author keywords

BAL; Pulmonary strongyloidiasis

Indexed keywords

IVERMECTIN; PREDNISOLONE; TIABENDAZOLE;

AGED; ARTICLE; CASE REPORT; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DYSPNEA; EMERGENCY WARD; ENDEMIC DISEASE; FECES ANALYSIS; FEMALE; FOLLOW UP; GRAM STAINING; HUMAN; IMMUNE DEFICIENCY; LARVA; LOBAR PNEUMONIA; LONG TERM CARE; LUNG INFECTION; LUNG LAVAGE; NONHUMAN; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UVEITIS;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; ANIMALS; ANTINEMATODAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IVERMECTIN; LUNG DISEASES, PARASITIC; PREDNISOLONE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; THIABENDAZOLE; UVEITIS;

EID: 4644224914     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.731     Document Type: Article

References (17)

1. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 33: 1040-1046, 2001.
2. Adedayo O, Grell G, Bellot P. Hyperinfective strongyloidiasis in the medical ward: Review of 27 cases in 5 years. South Med J 95: 711-716, 2002.
3. Genta RM. Global prevalence of strongyloidiasis: Critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis 11: 755-767, 1989.
4. Asato R, Nakasone T, Yoshida C, et al. Current status of Strongyloides infection in Okinawa, Japan. Jpn J Trop Med Hyg 20: 169-173, 1992.
5. Milder JE, et al. Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterology 80: 1481-1488, 1981.
6. Hirata T, Saito A. Strongyloidiasis. Kensa to Gijutsu 30: 6-9, 2002.
7. Zaha O, Saito A. Epidemiology of strongyloidiasis and clinical disease state. Modern Media 46: 226-231, 2000.
8. Yamamoto T, Yamori S. Strongyloidiasis. Ryoikibetsu Shokogun Shirizu 24: 442-445, 1999.
9. Woodring JH, Halfhill H 2nd, Berger R, Reed JC, Moser N. Clinical and imaging features of pulmonary strongyloidiasis. South Med J 89: 10-19, 1996.
10. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infec Dis 3: 397-407, 1981.
11. Saito A. Strongyloidiasis: epidemiology, clinical manifestations and new methods for diagnosis and treatment. J Infect Chemother 1: 98-106, 1995.
12. Longworth DL, Weller PF. Hyperinfection syndrome with strongyloidiasis. Curr Clin Topics Infect Dis. 7th ed. McGraw-Hill, New York, 1986: 1-26.
13. Wehner JH, Kirsh CM. Pulmonary manifestations of strongyloidiasis. Semin Respir Infect 2: 122-129, 1997.
14. Ting YM. Pulmonary strongyloidiasis-case report of 2 cases. Kaohisiung J Med Sci 16: 269-274, 2000.
15. Woodering JH, Harfhill H 2nd, Reed JC. Pulmonary strongyloidiasis: clinical and imaging features. AJR 162: 537-542, 1994.
16. Fraser RS, Muller NL, Colman N, Pare PD. Protozoa, helminths, arthropods and leeches. Fraser and Pare's Diagnosis of Diseases of the Chest, 4th ed. 1999: 1040-1043.
17. Chu E, Whitlock WL, Dietrich RA. Pulmonary hyperinfection syndrome with Strongyloides stercoralis. Chest 97: 1475-1477, 1990.